Immunome, Inc. has grown revenue 73% a year over three years and 1016% a year over five. Revenue growth, 3-year annual rate: +73% (Biotechnology median +21%). Revenue growth, 5-year rate: +1016%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

IMNMImmunome, Inc.

HealthcareUSD

$28.77

$8.9952 weeks$29.84

Is it growing?

Is IMNM growing?

Immunome, Inc. has grown revenue 73% a year over three years and 1016% a year over five.

+73%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +1016%
Revenue growth, 5-year rate · +73% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›